- Khoo SP, Bhoo-Pathy N, Yap SH, Anwar Shafii MK, Hairizan Nasir N, Belinson J, et al. Prevalence and sociodemographic correlates ofcervicovaginal humanpapillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population. SexTransm Infect. 2018;94(4):277-83.
- Webb S, Mat Ali N, Sawyer A, Clark DJ, Brown MA, Augustin Y, et al. Patient preference and acceptability of self-sampling for cervicalscreening in colposcopy clinicattenders: A cross-sectional semi-structured survey. PLOS Glob Public Health. 2024;4(5):e0003186.
- Woo YL, Khoo SP, Gravitt P, Hawkes D, Rajasuriar R, Saville M. The Implementation of a Primary HPV Self-Testing Cervical ScreeningProgram in Malaysia throughProgram ROSE-Lessons Learnt and Moving Forward. Curr Oncol. 2022;29(10):7379-87.
- Khoo SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, Gravitt P, Ng CW, et al. Changes in genital Human Papillomavirus (HPV)prevalence among urbanfemales a decade after the Malaysian HPV vaccination program. PLoS One. 2022;17(12):e0278477.
- Khoo SP, Lim WT, Rajasuriar R, Nasir NH, Gravitt P, Woo YL. The Acceptability and Preference of Vaginal Self-sampling for HumanPapillomavirus (HPV) Testing amonga Multi-ethnic Asian Female Population. Cancer Prev Res (Phila). 2021;14(1):105-12.
- Lycke KD, Steben M, Garland SM, Woo YL, Cruickshank ME, Perkins RB, et al. An updated understanding of the natural history ofcervical human papillomavirusinfection-clinical implications. Am J Obstet Gynecol. 2025.
- Shastri SS, Temin S, Almonte M, Basu P, Campos NG, Gravitt PE, et al. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update. JCO GlobOncol. 2022;8:e2200217.
- Woo YL, Omar SZ. Human papillomavirus vaccination in the resourced and resource-constrained world. Best Pract ResClin Obstet Gynaecol. 2011;25(5):597-603.
- Costa T, Bateson D, Woo YL. Enhancing equity in cervical screening – initiatives to increase screening participation.Curr Opin Obstet Gynecol. 2024;36(5):345-52.
- Bateson D, Woo YL, Kulkarni J. Elimination of cervical cancer: ensuring equity. Lancet Public Health. 2023;8(4):e248-e9.
- Tse KY, Tan AL, Subedi K, Pervin S, Gupta K, Tjokroprawiro BA, et al. The AOFOG recommendations on human papillomavirusvaccination in the Asia-Pacific region. JObstet Gynaecol Res. 2024;50 Suppl 1:95-102.
- Woo YL, Gravitt P, Khor SK, Ng CW, Saville M. Accelerating action on cervical screening in lower- and middle-income countries (LMICs)post COVID-19 era. Prev Med.2021;144:106294.
- Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H, et al. Towards elimination of cervical cancer – humanpapillomavirus (HPV) vaccination andcervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries.Lancet Reg Health West Pac. 2023;39:100860.